AstriVax
PrivateLast Round
Grant
Dec 12, 2023
Total Funding Raised
$35.83M
Company Overview
AstriVax is a clinical-stage biopharmaceutical company developing a DNA-based, plug-and-play vaccine platform to create thermostable vaccines for infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AstriVax Comps
Public and private peers based on sector, stage, and business model.
AstriVax Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 12, 2023 | ||||
| Grant | May 30, 2023 | ||||
| Seed | Aug 25, 2022 |
Key People
Founding team and executive leadership
AstriVax Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ackermans & van Haaren | Seed |
| Fund+ | Seed |
| KU Leuven Research & Development (LRD) | Seed |
| Thuja Capital | Seed |
| V-Bio Ventures | Seed |
| VLAIO | Grant |
| BNP Paribas Fortis Private Equity | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 12, 2025
Dieter Weinand appointed Chair of the Board of Directors.
- May 30, 2023
$2.68M grant received from VLAIO.
AstriVax Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AstriVax's valuation, stock price, and market status.
